Fact CheckerSign in

NCT06549829Completed

the Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Liver Carcinoma

Nutrition-Optimized Prehabilitation's Impact on Perioperative Outcomes in Primary Liver Carcinoma: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 4 Nov 2026

Brief summary (registry, in English)

This study aimed to evaluate whether nutritional optimization-led triple prehabilitation could improve perioperative nutritional status, promote postoperative recovery, and reduce postoperative complications in patients with primary liver cancer undergoing surgery. After screening according to the inclusion and exclusion criteria, eligible patients were randomized into experimental and control groups. Both groups received exercise and psychological interventions; for nutritional intervention, the experimental group received an ordinary diet plus oral nutritional supplementation, whereas the control group received an ordinary diet alone. Routine clinical blood tests were performed at the time of enrollment and on the first, third and fifth days after surgery. Enrolled patients were followed up by telephone or outpatient clinic at 1 month postoperatively.

Status (registry)
Completed
Study type
Interventional
Enrollment
132 (actual)
First submitted
13 May 2024
Start date
10 May 2024
Primary completion date
1 Sept 2026
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
NCT number
NCT06549829

What you commit to

  • Study type: Interventional
  • Participants enrolled: 132
  • From 10 May 2024 to the primary completion date, 1 Sept 2026
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with liver metastases or combined with other tumors.
    • Patients with allergy to the ingredients of nutritional preparations. ③Patients with severe malnutrition who cannot eat by mouth. ④Patients with hyperthyroidism, fistula, and combined digestive system diseases.

Who the study is looking for

  • Patients diagnosed with primary liver cancer.
    • Patients between the ages of 18 and 80.
    • Patients who are feasible for surgical treatment after clinical evaluation.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Coordinator of this site? Confirm its status
HangzhouChinaUnknown status
Huzhou Central Hospital
Coordinator of this site? Confirm its status
HuzhouChinaUnknown status
Shangrao People's Hospital
Coordinator of this site? Confirm its status
ShangraoChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.